GlaxoSmithKline S.A.E Stock Price

CASE:BIOC Community·ج.م5.1b Market Cap

0 Narratives written by author
0 Comments on narratives written by author
3 Fair Values set on narratives written by author

Create a narrative

BIOC Share Price Performance

ج.م61.28

22.11 (56.45%)

ج.م61.28

22.11 (56.45%)

ج.م61.28

Sun, 22 Mar 26

Share Pricen/a

BIOC Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Slight risk with mediocre balance sheet.

4 Risks

0 Rewards

View Full Analysis

GlaxoSmithKline S.A.E Key Details

Last Reported Earnings

Sep 30, 2025

Next Reporting Earnings

n/a

: 1.18
: 15.98%
: 2.63%
: 58.2%

View Full Analysis

About BIOC

Founded: 1981
Employees: n/a
CEO: Heba El Morshedy
WebsiteView website: www.gsk.com/en-gb/contact-us/worldwide/egypt

GlaxoSmithKline S.A.E engages in production of pharmaceutical chemicals. The company is involved in manufacture of general and specialty medicines, and vaccines. GlaxoSmithKline S.A.E was founded in 1981 and is based in New Cairo, Egypt. GlaxoSmithKline S.A.E operates as a subsidiary of Glaxo Group Limited.